PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

DHSC says over four million people have received first COVID-19 vaccine dose

The Department of Health and Social Care (DHSC) has announced that over four million people in the UK have now received their first dose of a COVID-19 vaccine.

Between 8 December 2020 and 17 January 2021, a total of 4.06 million people have been vaccinated by the NHS. This includes over half of people aged 80 years and older, as well as over half of elderly care home residents.

Prime Minister Boris Johnson has previously set a tatget of offering COVID-19 vaccines to the top four priority groups by the middle of February, which consists of around 15 million people.

Yesterday, the NHS began offering vaccines to those aged 70 years and over and the clinically extremely vulnerable in England – reflecting the next two priority groups identified by the Joint Committee on Vaccination and Immunisation (JCVI).

The first two priority groups which have been receiving their vaccines include care home residents and staff, people aged 80 and over and frontline health and care staff.

“This is the biggest medical deployment in British history and it’s one of the biggest civilian operations that this country’s ever undertaken,” said Health Secretary Matt Hancock.

“We’re on track to deliver our plan to vaccinate the most vulnerable groups by the middle of February, the groups that account for 88% of COVID-19 deaths.

“Our approach is, of course, to save as many lives as possible – as quickly as possible and to reduce the pressure on the NHS,” he added.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026